بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
بيكالوتاميد تيڤع ٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 50 mg - tablets - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.
bicalutamida bluefish 50mg 30 comprimidos recubiertos pelicula efg
bicalutamida pensa 50mg 30 comprim recub pelic efg
bicalutamida aristo efg 50 mg 30 comprimits recoberts
bicalutamida sandoz 50mg 30 comprimidos recubiertos pelicula efg